Detalles de la búsqueda
1.
Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.
J Clin Microbiol
; 56(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29118165
2.
Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.
HIV Clin Trials
; 14(6): 261-73, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24334179
3.
Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Dermatol Surg
; 38(7 Pt 2): 1193-205, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22759256
4.
Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trial.
HIV Clin Trials
; 11(5): 239-47, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21126954
5.
Estimated glomerular filtration rates through 144âweeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.
HIV Clin Trials
; 16(4): 125-9, 2015 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26133089
6.
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study).
AIDS Res Ther
; 6: 3, 2009 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19358725
7.
Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection.
AIDS Res Hum Retroviruses
; 23(1): 1-9, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17263626
8.
Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.
HIV Clin Trials
; 18(5-6): 205-213, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29210625
9.
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.
Lancet HIV
; 4(5): e205-e213, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28259776
10.
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.
Lancet HIV
; 4(5): e195-e204, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28259777
11.
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV.
AIDS
; 18(17): 2269-76, 2004 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-15577539
12.
HIV-1 transmission patterns in antiretroviral therapy-naïve, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencing.
PLoS One
; 9(2): e89611, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24586911
13.
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.
Lancet Infect Dis
; 12(1): 27-35, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22015077
14.
Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study).
J Acquir Immune Defic Syndr
; 41(5): 598-606, 2006 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16652033
Resultados
1 -
14
de 14
1
Próxima >
>>